# KCNJ10

## Overview
KCNJ10 is a gene that encodes the potassium inwardly rectifying channel subfamily J member 10, commonly referred to as the Kir4.1 channel. This protein is a transmembrane channel that plays a pivotal role in maintaining potassium ion homeostasis across various tissues, including the brain, kidneys, and inner ear. As a member of the inwardly rectifying potassium channel family, Kir4.1 is integral to processes such as neuronal repolarization, renal electrolyte balance, and auditory function. The channel's structure includes two transmembrane regions and an extracellular pore-forming domain, which are essential for its function in selectively allowing potassium ions to pass through the cell membrane. Mutations in the KCNJ10 gene can lead to significant clinical conditions, such as EAST syndrome and SeSAME syndrome, which are characterized by neurological and renal symptoms due to disrupted potassium ion homeostasis (Scholl2009Seizures; Bockenhauer2009Epilepsy).

## Structure
The KCNJ10 gene encodes the Kir4.1 channel, an inwardly rectifying potassium channel. The primary structure of the Kir4.1 subunit includes two transmembrane regions, an extracellular pore-forming region with a -G-Y-G- signature sequence acting as an ion filter, and intracellular N- and C-terminal domains (Huang2023Heterozygous; Nicita2018Novel). The secondary structure likely involves alpha-helices, typical of transmembrane proteins, although specific details are not provided in the context.

The tertiary structure of Kir4.1 involves the arrangement of these helices around the pore, forming a channel that allows selective potassium ion passage. The quaternary structure is tetrameric, as Kir channels typically form homotetramers, with each subunit contributing to the overall channel structure (Zangerl-Plessl2019Disease).

Kir4.1 is known to interact with phosphatidylinositol 4, 5-bisphosphate (PIP2), which is essential for channel gating, and mutations affecting this interaction can impair channel function (Nicita2018Novel). The channel is also involved in forming heterotetramers with Kir5.1, which can influence its pH sensitivity and functional properties (Sepúlveda2015Molecular).

## Function
The KCNJ10 gene encodes the Kir4.1 potassium channel, which is part of the inwardly rectifying potassium channel family. This channel plays a crucial role in maintaining potassium ion homeostasis and the resting membrane potential in various tissues, including the brain, kidneys, and inner ear. In the brain, KCNJ10 is primarily expressed in glial cells, such as astrocytes, where it facilitates the clearance of potassium ions through a process known as spatial buffering. This function is essential for neuronal repolarization after excitatory stimuli, helping to prevent prolonged neuronal depolarization and reduce seizure susceptibility (Scholl2009Seizures).

In the kidneys, KCNJ10 is located on the basolateral membrane of epithelial cells in the distal convoluted tubule. It contributes to renal electrolyte homeostasis by recycling potassium ions, which is essential for the function of the Na+/K+-ATPase pump. This process is critical for maintaining the electrochemical gradient necessary for sodium reabsorption, thereby regulating blood pressure and volume homeostasis (Bockenhauer2009Epilepsy).

In the inner ear, KCNJ10 is involved in generating the endocochlear potential, which is vital for normal auditory function. The channel is expressed in the membranes of intermediate cells in the cochlea's stria vascularis, playing a key role in potassium secretion and sensory transduction in hair cells (Marcus2002KCNJ10).

## Clinical Significance
Mutations in the KCNJ10 gene, which encodes the Kir4.1 potassium channel, are associated with several neurological and renal disorders. Notably, these mutations cause EAST syndrome (epilepsy, ataxia, sensorineural deafness, and tubulopathy) and SeSAME syndrome (seizures, sensorineural deafness, ataxia, mental retardation, and electrolyte imbalance) (Scholl2009Seizures; Bockenhauer2009Epilepsy). These conditions are characterized by a combination of neurological symptoms, such as seizures and ataxia, and renal symptoms, including electrolyte imbalances and tubulopathy (Lo2022EASTSeSAME).

Mutations in KCNJ10 lead to a loss of function in the Kir4.1 channel, disrupting potassium ion homeostasis and affecting neuronal and renal functions. Specific mutations, such as p.R65P and p.G77R, have been identified in affected individuals, leading to reduced potassium currents and associated clinical symptoms (Bockenhauer2009Epilepsy). In some cases, mutations like G163D and R171Q result in distinctive phenotypes, including ataxia, sensorineural hearing loss, and spasticity, without renal manifestations (Morin2020Novel).

The dysfunction of Kir4.1 channels due to these mutations is implicated in the pathogenesis of these syndromes, highlighting the critical role of KCNJ10 in maintaining normal physiological functions across multiple organ systems (Kinboshi2020Role).

## Interactions
The KCNJ10 gene encodes the Kir4.1 potassium channel, which participates in several important protein interactions. Kir4.1 forms heteromeric channels with Kir5.1, encoded by the KCNJ16 gene, which are crucial for its function in various tissues, including the kidney and central nervous system (Lo2022EASTSeSAME). These interactions are essential for maintaining potassium conductance and membrane potential, particularly in the distal convoluted tubule of the kidney (Lo2022EASTSeSAME).

Kir4.1 also interacts with proteins such as GlialCAM and AQP-4 in oligodendrocytes, forming a complex that includes ClC-2, a chloride channel. This complex is involved in maintaining charge neutrality and isoosmolarity during myelination (Lo2022EASTSeSAME). In the retina, Kir4.1 forms both homomeric and heteromeric channels with Kir5.1, contributing to potassium conductance in Müller cells (Lo2022EASTSeSAME).

Additionally, KCNJ10 interacts with phosphatidylinositol bisphosphate (PIP2), a membrane lipid that is crucial for channel gating. Mutations affecting PIP2 binding can alter Kir4.1 function, impacting its role in maintaining membrane excitability and potassium homeostasis (Nadella2019Identification; Nicita2018Novel).


## References


[1. (Morin2020Novel) Matias Morin, Anna-Lena Forst, Paula Pérez-Torre, Adriano Jiménez-Escrig, Verónica Barca-Tierno, Eva García-Galloway, Richard Warth, Jose Luis Lopez-Sendón Moreno, and Miguel Angel Moreno-Pelayo. Novel mutations in the kcnj10 gene associated to a distinctive ataxia, sensorineural hearing loss and spasticity clinical phenotype. neurogenetics, 21(2):135–143, February 2020. URL: http://dx.doi.org/10.1007/s10048-020-00605-6, doi:10.1007/s10048-020-00605-6. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s10048-020-00605-6)

2. (Huang2023Heterozygous) Heterozygous KCNJ10 variants affecting Kir4.1 channel cause paroxysmal kinesigenic dyskinesia. This article has 0 citations.

[3. (Nicita2018Novel) Francesco Nicita, Giorgio Tasca, Marta Nardella, Emanuele Bellacchio, Ilaria Camponeschi, Gessica Vasco, Tommaso Schirinzi, Enrico Bertini, and Ginevra Zanni. Novel homozygous kcnj10 mutation in a patient with non-syndromic early-onset cerebellar ataxia. The Cerebellum, 17(4):499–503, February 2018. URL: http://dx.doi.org/10.1007/s12311-018-0924-7, doi:10.1007/s12311-018-0924-7. This article has 10 citations.](https://doi.org/10.1007/s12311-018-0924-7)

[4. (Sepúlveda2015Molecular) Francisco V. Sepúlveda, L. Pablo Cid, Jacques Teulon, and María Isabel Niemeyer. Molecular aspects of structure, gating, and physiology of ph-sensitive background k2pand kir k+-transport channels. Physiological Reviews, 95(1):179–217, January 2015. URL: http://dx.doi.org/10.1152/physrev.00016.2014, doi:10.1152/physrev.00016.2014. This article has 85 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1152/physrev.00016.2014)

[5. (Bockenhauer2009Epilepsy) Detlef Bockenhauer, Sally Feather, Horia C. Stanescu, Sascha Bandulik, Anselm A. Zdebik, Markus Reichold, Jonathan Tobin, Evelyn Lieberer, Christina Sterner, Guida Landoure, Ruchi Arora, Tony Sirimanna, Dorothy Thompson, J. Helen Cross, William van’t Hoff, Omar Al Masri, Kjell Tullus, Stella Yeung, Yair Anikster, Enriko Klootwijk, Mike Hubank, Michael J. Dillon, Dirk Heitzmann, Mauricio Arcos-Burgos, Mark A. Knepper, Angus Dobbie, William A. Gahl, Richard Warth, Eamonn Sheridan, and Robert Kleta. Epilepsy, ataxia, sensorineural deafness, tubulopathy, andkcnj10mutations. New England Journal of Medicine, 360(19):1960–1970, May 2009. URL: http://dx.doi.org/10.1056/NEJMoa0810276, doi:10.1056/nejmoa0810276. This article has 624 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1056/NEJMoa0810276)

[6. (Nadella2019Identification) Ravi K. Nadella, Anirudh Chellappa, Anand G. Subramaniam, Ravi Prabhakar More, Srividya Shetty, Suriya Prakash, Nikhil Ratna, V. P. Vandana, Meera Purushottam, Jitender Saini, Biju Viswanath, P. S. Bindu, Madhu Nagappa, Bhupesh Mehta, Sanjeev Jain, and Ramakrishnan Kannan. Identification and functional characterization of two novel mutations in kcnj10 and pi4kb in sesame syndrome without electrolyte imbalance. Human Genomics, October 2019. URL: http://dx.doi.org/10.1186/s40246-019-0236-0, doi:10.1186/s40246-019-0236-0. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s40246-019-0236-0)

[7. (Scholl2009Seizures) Ute I. Scholl, Murim Choi, Tiewen Liu, Vincent T. Ramaekers, Martin G. Häusler, Joanne Grimmer, Sheldon W. Tobe, Anita Farhi, Carol Nelson-Williams, and Richard P. Lifton. Seizures, sensorineural deafness, ataxia, mental retardation, and electrolyte imbalance (sesame syndrome) caused by mutations in kcnj10. Proceedings of the National Academy of Sciences, 106(14):5842–5847, April 2009. URL: http://dx.doi.org/10.1073/pnas.0901749106, doi:10.1073/pnas.0901749106. This article has 403 citations.](https://doi.org/10.1073/pnas.0901749106)

[8. (Zangerl-Plessl2019Disease) Eva-Maria Zangerl-Plessl, Muge Qile, Meye Bloothooft, Anna Stary-Weinzinger, and Marcel A. G. van der Heyden. Disease associated mutations in kir proteins linked to aberrant inward rectifier channel trafficking. Biomolecules, 9(11):650, October 2019. URL: http://dx.doi.org/10.3390/biom9110650, doi:10.3390/biom9110650. This article has 25 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/biom9110650)

[9. (Lo2022EASTSeSAME) Jacky Lo, Anna-Lena Forst, Richard Warth, and Anselm A. Zdebik. East/sesame syndrome and beyond: the spectrum of kir4.1- and kir5.1-associated channelopathies. Frontiers in Physiology, March 2022. URL: http://dx.doi.org/10.3389/fphys.2022.852674, doi:10.3389/fphys.2022.852674. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fphys.2022.852674)

[10. (Kinboshi2020Role) Masato Kinboshi, Akio Ikeda, and Yukihiro Ohno. Role of astrocytic inwardly rectifying potassium (kir) 4.1 channels in epileptogenesis. Frontiers in Neurology, December 2020. URL: http://dx.doi.org/10.3389/fneur.2020.626658, doi:10.3389/fneur.2020.626658. This article has 27 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fneur.2020.626658)

[11. (Marcus2002KCNJ10) Daniel C. Marcus, Tao Wu, Philine Wangemann, and Paulo Kofuji. Kcnj10 (kir4.1) potassium channel knockout abolishes endocochlear potential. American Journal of Physiology-Cell Physiology, 282(2):C403–C407, February 2002. URL: http://dx.doi.org/10.1152/ajpcell.00312.2001, doi:10.1152/ajpcell.00312.2001. This article has 264 citations.](https://doi.org/10.1152/ajpcell.00312.2001)